title: The search for biochemical predictors of the NAT2 phenotype to optimize prophylaxis and pharmacotherapy of hepatic cirrhosis.
authors.affiliation: Center of Theoretical Problems of Physicochemical Pharmacology, Russian Academy of Sciences, Moscow, 119991 Russia.
authors.forename: L A
authors.initials: LA
authors.lastname: Radkevich
authors.forename: I B
authors.initials: IB
authors.lastname: Korshunov
authors.forename: N E
authors.initials: NE
authors.lastname: Pyn'ko
authors.forename: N V
authors.initials: NV
authors.lastname: Morozova
authors.forename: E V
authors.initials: EV
authors.lastname: Markarova
authors.forename: D S
authors.initials: DS
authors.lastname: Nechaev
authors.forename: L A
authors.initials: LA
authors.lastname: Piruzyan
mesh_terms: D000107:Acetylation; D000328:Adult; D001191:Arylamine N-Acetyltransferase / Q000737:chemistry*; D001663:Bilirubin / Q000737:chemistry / Q000378:metabolism; D002779:Cholestasis / Q000378:metabolism; D005260:Female; D020022:Genetic Predisposition to Disease; D022781:Hepatocytes / Q000378:metabolism; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy* / Q000473:pathology* / Q000517:prevention & control; D008107:Liver Diseases / Q000175:diagnosis / Q000473:pathology; D008297:Male; D008875:Middle Aged; D010641:Phenotype
chemical_list: D001191:Arylamine N-Acetyltransferase; C478900:NAT2 protein, human; D001663:Bilirubin